K. Stoeckel

3.3k total citations
69 papers, 2.7k citations indexed

About

K. Stoeckel is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, K. Stoeckel has authored 69 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pharmacology, 26 papers in Oncology and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in K. Stoeckel's work include Antibiotics Pharmacokinetics and Efficacy (43 papers), Drug Transport and Resistance Mechanisms (25 papers) and Pharmaceutical studies and practices (11 papers). K. Stoeckel is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (43 papers), Drug Transport and Resistance Mechanisms (25 papers) and Pharmaceutical studies and practices (11 papers). K. Stoeckel collaborates with scholars based in Switzerland, United States and Canada. K. Stoeckel's co-authors include H. Thoenen, Martin E. Schwab, Patrick J. McNamara, Walter Ziegler, William L. Hayton, U. Paravicini, U. Otten, Michel Goedert, C. Gagnon and Gordon Guroff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Clinical Infectious Diseases.

In The Last Decade

K. Stoeckel

69 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Stoeckel Switzerland 29 1.0k 785 592 430 319 69 2.7k
Keiji Hirai Japan 31 815 0.8× 356 0.5× 1.4k 2.4× 284 0.7× 987 3.1× 175 3.2k
Richard B. Clark United States 33 157 0.2× 943 1.2× 1.7k 2.9× 309 0.7× 255 0.8× 122 3.2k
James A. Dowell United States 30 598 0.6× 126 0.2× 1.0k 1.7× 615 1.4× 220 0.7× 62 2.9k
Ping Lü China 28 320 0.3× 202 0.3× 1.1k 1.8× 298 0.7× 129 0.4× 69 2.6k
Romuald Bellmann Austria 25 316 0.3× 673 0.9× 547 0.9× 567 1.3× 48 0.2× 92 2.2k
Martin Herbst Germany 13 224 0.2× 395 0.5× 1.0k 1.7× 167 0.4× 48 0.2× 25 2.5k
Vesna Eraković Haber Croatia 25 288 0.3× 182 0.2× 606 1.0× 625 1.5× 142 0.4× 73 2.5k
Richard V. Benya United States 38 166 0.2× 1.4k 1.8× 1.9k 3.1× 793 1.8× 254 0.8× 89 4.4k
H. Richard Adams United States 27 297 0.3× 283 0.4× 676 1.1× 266 0.6× 25 0.1× 100 2.6k
Navneet K. Dhillon United States 31 190 0.2× 167 0.2× 1.4k 2.4× 443 1.0× 705 2.2× 93 3.6k

Countries citing papers authored by K. Stoeckel

Since Specialization
Citations

This map shows the geographic impact of K. Stoeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Stoeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Stoeckel more than expected).

Fields of papers citing papers by K. Stoeckel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Stoeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Stoeckel. The network helps show where K. Stoeckel may publish in the future.

Co-authorship network of co-authors of K. Stoeckel

This figure shows the co-authorship network connecting the top 25 collaborators of K. Stoeckel. A scholar is included among the top collaborators of K. Stoeckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Stoeckel. K. Stoeckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoeckel, K., William L. Hayton, & David J. Edwards. (2015). Clinical Pharmacokinetics of Oral Cephalosporins. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 47. 34–71. 1 indexed citations
2.
Schmitt‐Hoffmann, Anne, et al.. (2011). Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid). Clinical and Experimental Dermatology. 36. 18–23. 12 indexed citations
3.
Roos, Brigitte, Jochen Spickermann, K. Stoeckel, et al.. (2011). Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema. Clinical and Experimental Dermatology. 36. 29–34. 14 indexed citations
4.
Schmitt‐Hoffmann, Anne, Brigitte Roos, Jochen Spickermann, et al.. (2009). Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557. Antimicrobial Agents and Chemotherapy. 53(11). 4885–4890. 59 indexed citations
5.
Kovács, Péter, et al.. (1999). High-Dose Omeprazole: Use of a Multiple-Dose Study Design to Assess Bioequivalence and Accuracy of CYP2C19 Phenotyping. Therapeutic Drug Monitoring. 21(5). 526–526. 5 indexed citations
6.
Stoeckel, K., Moshe Harell, & Dan Mei. (1996). Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state. Antimicrobial Agents and Chemotherapy. 40(3). 780–783. 5 indexed citations
7.
Blouin, Robert A. & K. Stoeckel. (1993). Cefetamet Pivoxil Clinical Pharmacokinetics. Clinical Pharmacokinetics. 25(3). 172–188. 17 indexed citations
8.
Edwards, David J. & K. Stoeckel. (1992). The Pharmacokinetics of New Oral Cephalosporins in Children. Chemotherapy. 38(2). 2–9. 5 indexed citations
9.
Cullmann, W., et al.. (1992). Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. International Journal of Antimicrobial Agents. 1(4). 175–191. 18 indexed citations
10.
Holford, Nicholas H. G., et al.. (1992). Models for describing absorption rate and estimating extent of bioavailability: Application to cefetamet pivoxil. Journal of Pharmacokinetics and Biopharmaceutics. 20(5). 421–442. 39 indexed citations
11.
McNamara, Patrick J., et al.. (1990). Ceftriaxone binding to human serum albumin. Biochemical Pharmacology. 40(6). 1247–1253. 43 indexed citations
12.
Stoeckel, K., Michael Mayersohn, Christian Andressen, et al.. (1990). Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function. Acta Psychiatrica Scandinavica. 82(S360). 94–97. 48 indexed citations
13.
Stoeckel, K., et al.. (1989). Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Current Medical Research and Opinion. 11(7). 432–441. 20 indexed citations
14.
Stoeckel, K., et al.. (1988). Effect of probenecid on the elimination and protein binding of ceftriaxone. European Journal of Clinical Pharmacology. 34(2). 151–156. 25 indexed citations
15.
Islam, Asma, Thomas Butler, S. Nath, et al.. (1988). Randomized Treatment of Patients with Typhoid Fever by Using Ceftriaxone or Chloramphenicol. The Journal of Infectious Diseases. 158(4). 742–747. 43 indexed citations
16.
McNamara, Patrick J., et al.. (1988). Protein Binding of Ceftriaxone in Extravascular Fluids. Journal of Pharmaceutical Sciences. 77(5). 401–404. 17 indexed citations
17.
Hayton, William L., et al.. (1986). Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy. European Journal of Clinical Pharmacology. 30(4). 445–451. 31 indexed citations
18.
Koup, Jeffrey R., et al.. (1984). Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. The Journal of Pediatrics. 105(3). 475–481. 53 indexed citations
19.
Stoeckel, K., et al.. (1984). Single-dose ceftriaxone kinetics in liver insufficiency. Clinical Pharmacology & Therapeutics. 36(4). 500–509. 33 indexed citations
20.
Weidekamm, E., et al.. (1984). Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrobial Agents and Chemotherapy. 26(6). 898–902. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiji Hirai Breakdown of academic impact, for papers by Richard B. Clark Breakdown of academic impact, for papers by James A. Dowell Breakdown of academic impact, for papers by Ping Lü Breakdown of academic impact, for papers by Romuald Bellmann Breakdown of academic impact, for papers by Martin Herbst Breakdown of academic impact, for papers by Vesna Eraković Haber Breakdown of academic impact, for papers by Richard V. Benya Breakdown of academic impact, for papers by H. Richard Adams Breakdown of academic impact, for papers by Navneet K. Dhillon
Rankless by CCL
2026